Clinical Trial Update: Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs Rosiglitazone

View source ↗

Summary

A completed clinical trial compared add-on therapy with DPP-4 inhibitors versus rosiglitazone in type 2 diabetes, focusing on prescription patterns, resource ut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitors (class)
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED